Skip to main content
. 2019 Apr 16;15:24. doi: 10.1186/s13223-018-0314-1

Fig. 1.

Fig. 1

Early and late phases showing the pathophysiological processes and drivers of allergic rhinitis and the potential sites for pharmacological intervention. ECP eosinophil cationic protein, ICAM-1 intercellular adhesion molecule-1, IgE immunoglobulin E, IL interleukin